SKI Market

A+| A| A-|

Indian Indices

Sensex

77,312.17 570.35
( 0.74%)

Global Indices

Nasdaq

52,499.17 129.78
(0.25%)

Dow Jones

7,562.80 59.09
(0.79%)

Hang Seng

67,966.49 1,147.44
(1.72%)

Nikkei 225

10,472.08 -16.96
(-0.16%)

Forex

USD-INR

95.15 -0.21
(-0.22%)

EUR-INR

108.73 -0.26
(-0.24%)

GBP-INR

127.27 -0.11
(-0.09%)

JPY-INR

0.59 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

29.31

67529.71

EPS(TTM)

Face Value()

Div & Yield %

192.67

0.94

Back

genpharmasec limited

Avro India standalone net profit rises 2.88% in the December 2025 quarter

Feb 15,2026

Net profit of Avro India rose 2.88% to Rs 1.07 crore in the quarter ended December 2025 as against Rs 1.04 crore during the previous quarter ended December 2024. Sales rose 0.96% to Rs 24.29 crore in the quarter ended December 2025 as against Rs 24.06 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	24.29	24.06	1
OPM %	2.76	6.32	-
PBDT	2.58	2.51	3
PBT	1.41	1.42	-1
NP	1.07	1.04	3

77,312.17 570.35 ( 0.74%)

52,499.17 129.78 (0.25%)

7,562.80 59.09 (0.79%)

67,966.49 1,147.44 (1.72%)

10,472.08 -16.96 (-0.16%)

95.15 -0.21 (-0.22%)

108.73 -0.26 (-0.24%)

127.27 -0.11 (-0.09%)

0.59 0.00 (-0.14%)